Arrowhead Pharmaceuticals Inc. (ARWR) Tops Q1 EPS by 10c
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $88.70 +2.38%
Financial Fact:
General and administrative expenses: 2.28M
Today's EPS Names:
ELWT, CAAP, RNW, More
Financial Fact:
General and administrative expenses: 2.28M
Today's EPS Names:
ELWT, CAAP, RNW, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q1 EPS of $0.22, $0.10 better than the analyst estimate of $0.12. Revenue for the quarter came in at $264.03 million versus the consensus estimate of $227.61 million.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Infleqtion raises Q2 revenue to $13.5M after contract restatement
- HSBC Upgrades Blue Star Limited (BLSTR:IN) to Buy
- RBC Capital Downgrades Hermes International (RMS:FP) (HESAY) to Sector Perform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
